| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.3 | 0.08 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.053 | 0.09 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.09 |